FDA Inspection 814083 — UCLA Medical IRB 1 (OHRPP)
The FDA completed an inspection of UCLA Medical IRB 1 (OHRPP) on December 10, 2012 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 10, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
IRB